Form: CORRESP

A correspondence can be sent as a document with another submission type or can be sent as a separate submission.

November 4, 2021

   

VOLITIONRX LIMITED

13215 Bee Cave Parkway

Suite 125, Galleria Oaks B

Austin, Texas  78738

 

November 4, 2021

 

SUBMITTED VIA EDGAR

 

Securities and Exchange Commission

Division of Corporation Finance

100 F Street, N.E.

Washington, D.C.  20549

 

Attention:  Mr. Alan Campbell

 

 

Re:  

VolitionRx Limited Acceleration Request

 

 

Registration Statement on Form S-3

 

 

File No. 333-259783

 

 

 Requested Date:  November 8, 2021

 

 Requested Time:  5:00 P.M. Eastern Time

  

Ladies and Gentlemen:

 

Pursuant to Rule 461 of the Securities Act of 1933, as amended (the “Securities Act”), VolitionRx Limited, a Delaware corporation (the “Company”), hereby respectfully requests that the Securities and Exchange Commission (the “Commission”) take appropriate action to declare the above-captioned Registration Statement on Form S-3 effective at the “Requested Date” and “Requested Time” set forth above, or as soon thereafter as practicable.

 

Should the Commission have any questions regarding this acceleration request, please do not hesitate to contact Marc G. Alcser, an attorney with the Company’s outside legal counsel, Stradling Yocca Carlson & Rauth, P.C., via telephone at (949) 725-4136 or via email at malcser@stradlinglaw.com.

  

 

 

 

Sincerely,

 

 

 

 

 

 

 

VOLITIONRX LIMITED

 

       
/s/ Cameron Reynolds

 

 

 

 

 

 

Cameron Reynolds  
    President and Chief Executive Officer  

  

cc:

 

Stradling Yocca Carlson & Rauth, P.C.

Marc G. Alcser, Esq.